natpar
Commercial- Indications
- hypoparathyroidism
Company intelligence / Profile preview
Nova In Silico
Lyon, Francenovainsilico.ai ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Nova In Silico provides a commercialized SaaS platform called jinkō that enables pharmaceutical companies to simulate clinical trials using mechanistic models and virtual patients. The company demonstrated the ability of its technology by accurately predicting the results of AstraZeneca’s Phase III FLAURA2 trial in EGFR-mutant non-small cell lung cancer using only public data—completing simulations in weeks that mirrored years-long real-world trials. Their approach accelerates R&D timelines, reduces costs, de-risks decision-making, and supports regulatory submissions with synthetic evidence.
- Therapeutic areas
- OncologyCardiovascularMetabolic DisordersRare Diseases
- Modalities
- Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugateGene therapy
- Industry
- Drug Discovery Services
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Major global pharmaceutical companies (“half of the world’s largest pharmaceutical and drug development organizations”)academic research centers/university hospitals
Beyond the preview
Go deeper on Nova In Silico.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nova In Silico.